1. Outils pour la prédiction de la réponse tumorale et des tissus sains en oncologie radiothérapie
   O. Riou et al, 2019, Cancer/Radiothérapie CrossRef
2. Polymeric and lipid-based drug delivery systems for treatment of glioblastoma multiforme
   Ramesh Duwa et al, 2019, Journal of Industrial and Engineering Chemistry CrossRef
3. Genetic Alterations of Epidermal Growth Factor Receptor in Glioblastoma: The Usefulness of Immunohistochemistry
   Minju Lee et al, 2019, Applied Immunohistochemistry & Molecular Morphology CrossRef
4. Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway
   Shuai Wu et al, 2019, Cancer Cell International CrossRef
5. SNHG29 regulates miR-223-3p/CTNND1 axis to promote glioblastoma progression via Wnt/β-catenin signaling pathway
   Lizhang Han et al, 2019, Cancer Cell International CrossRef
6. miR‑7‑5p inhibits cell migration and invasion in glioblastoma through targeting SATB1
   Chang‑You Yin et al, 2018, Oncology Letters CrossRef
7. Role of Extracellular Vesicles in Glioma Progression: Deciphering Cellular Biological Processes to Clinical Applications
   Rashmi Rana et al, 2021, Current Topics in Medicinal Chemistry CrossRef
8. IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme
   Manasa Kalya et al, 2021, Frontiers in Genetics CrossRef
9. Master regulators associated with poor prognosis in glioblastoma multiforme
   M.P. Kalya et al, 2021, Biomeditsinskaya Khimiya CrossRef
10. Master Regulators Associated with Poor Prognosis in Glioblastoma Multiforme
    M. Kalya et al, 2021, Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry CrossRef
11. Genetics of Glioblastoma in Moroccan population: Review of literature
    Hossam Hilal El Idrissi et al, 2018, IBRO Reports CrossRef
12. EGFRAmplification andIDHMutations in Glioblastoma Patients of the Northeast of Morocco
    Nadia Senhaji et al, 2017, BioMed Research International CrossRef
13. RETRACTED ARTICLE: MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a
    Dongsheng Zhao et al, 2017, Molecular Neurobiology CrossRef
14. Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization
    Giuseppe Nicolò Fanelli et al, 2020, Frontiers in Oncology CrossRef
15. SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways
    Xizhao Wang et al, 2019, Cancer Cell International CrossRef
16. Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Response
    Prospero Civita et al, 2019, International Journal of Molecular Sciences CrossRef
17. Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues
    Prospero Civita et al, 2019, Frontiers in Oncology CrossRef
18. Highly Expressed CYBRD1 Associated with Glioma Recurrence Regulates the Immune Response of Glioma Cells to Interferon
    Mingjie Qing et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
19. CREB1-induced miR-1204 promoted malignant phenotype of glioblastoma through targeting NR3C2
    Xinli Zhao et al, 2020, Cancer Cell International CrossRef
20. Expression of miRNA-21, miRNA-107, miRNA-137 and miRNA-29b in meningioma
    Salim Katar et al, 2017, Clinical Neurology and Neurosurgery CrossRef